These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270 [TBL] [Abstract][Full Text] [Related]
3. Association between antipsychotic-induced metabolic side-effects and clinical improvement: a review on the Evidence for "metabolic threshold". Sharma E; Rao NP; Venkatasubramanian G Asian J Psychiatr; 2014 Apr; 8():12-21. PubMed ID: 24655620 [TBL] [Abstract][Full Text] [Related]
4. Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis. Verma S; Liew A; Subramaniam M; Poon LY Aust N Z J Psychiatry; 2009 Sep; 43(9):812-7. PubMed ID: 19670054 [TBL] [Abstract][Full Text] [Related]
5. Deterioration of metabolic parameters during short-term psychiatric inpatient treatment: a prospective naturalistic study. Rittmannsberger H; Fellinger J; Foff C; Walli G; Zaunmüller T Int J Psychiatry Clin Pract; 2012 Mar; 16(1):8-17. PubMed ID: 22122649 [TBL] [Abstract][Full Text] [Related]
6. Effects of second generation antipsychotics on leptin and ghrelin. Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280 [TBL] [Abstract][Full Text] [Related]
7. Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naïve first-episode psychosis patients. Diaz FJ; Perez-Iglesias R; Mata I; Martínez-Garcia O; Vázquez-Barquero JL; de Leon J; Crespo-Facorro B Schizophr Res; 2011 Sep; 131(1-3):82-9. PubMed ID: 21726981 [TBL] [Abstract][Full Text] [Related]
8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
10. [Metabolic side effects of second generation antipsychotics in drug-naïve patients: a preliminary study]. Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C Riv Psichiatr; 2009; 44(3):176-8. PubMed ID: 20066804 [TBL] [Abstract][Full Text] [Related]
11. Age-dependent metabolic effects of second-generation antipsychotics in second-generation antipsychotic-naïve French Canadian patients. Roy G; Bedard A; Desmarais PA; Jourdain F; Allen S; Michaud D; Ben Amor L J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):479-87. PubMed ID: 21186966 [TBL] [Abstract][Full Text] [Related]
12. Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia. Lindenmayer JP; Tedeschi F; Yusim A; Khan A; Kaushik S; Smith RC; Parakadavil M Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):185-92. PubMed ID: 22182455 [TBL] [Abstract][Full Text] [Related]
13. A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia. Kim E; Park DW; Choi SH; Kim JJ; Cho HS J Clin Psychopharmacol; 2008 Apr; 28(2):138-46. PubMed ID: 18344723 [TBL] [Abstract][Full Text] [Related]
14. Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment. Maayan LA; Vakhrusheva J Hum Psychopharmacol; 2010 Mar; 25(2):133-8. PubMed ID: 20196182 [TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of antipsychotics in prepubertal children: a retrospective chart review. Ebert T; Midbari Y; Shmilovitz R; Kosov I; Kotler M; Weizman A; Ram A J Child Adolesc Psychopharmacol; 2014 May; 24(4):218-22. PubMed ID: 24816004 [TBL] [Abstract][Full Text] [Related]
16. Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability. Noguera A; Ballesta P; Baeza I; Arango C; de la Serna E; González-Pinto A; Parellada M; Graell M; Moreno C; Otero S; Castro-Fornieles J J Clin Psychopharmacol; 2013 Aug; 33(4):463-71. PubMed ID: 23771198 [TBL] [Abstract][Full Text] [Related]